Glaucoma impacts over 3 million Americans, and is the leading cause of irreversible blindness today. At Ocuelar, the dynamic team of physicians, engineers, data scientists and innovators are all working together to solve this holy grail of Ophthalmology and improve medication adherence to prevent irreversible blindness. We have developed a groundbreaking smart cap technology that measures true medication compliance for glaucoma patients, who often struggle to adhere to their medication regimen. The compliance data from the smart cap interfaces seamlessly with the Ocuelar smartphone application and together they empower patients to improve their medication compliance through personalized reminder systems and powerful game designs that fosters intrinsic motivation.

Details and working of our MVP:

1)The orientation of the medicine bottle (attached within the unibody) is precisely monitored by the 6DOF IMU. When a patient picks up the unibody, opens the cap and tilts the bottle, the acce...
Glaucoma impacts over 3 million Americans, and is the leading cause of irreversible blindness today. At Ocuelar, the dynamic team of physicians, engineers, data scientists and innovators are all working together to solve this holy grail of Ophthalmology and improve medication adherence to prevent irreversible blindness. We have developed a groundbreaking smart cap technology that measures true medication compliance for glaucoma patients, who often struggle to adhere to their medication regimen. The compliance data from the smart cap interfaces seamlessly with the Ocuelar smartphone application and together they empower patients to improve their medication compliance through personalized reminder systems and powerful game designs that fosters intrinsic motivation.

Details and working of our MVP:

1)The orientation of the medicine bottle (attached within the unibody) is precisely monitored by the 6DOF IMU. When a patient picks up the unibody, opens the cap and tilts the bottle, the accelerometer coupled with the gyroscope in the IMU senses the motion. The IMU then registers an instance of medication if a certain combination of acceleration and orientation/angular velocity is achieved.
2. The intermediate processing of the data from the IMU is done by the secondary microcontroller.
3. The data is parallelly transferred onto the Radio Frequency Identification (RFID) tag, so that as soon as the unibody is kept onto the station, the RFID tag transmits the post-processed data onto the RFID reader, once they are in range.
4. The sensors on the unibody coupled with the microcontroller are together powered by a lithium polymer battery with an inductive charging circuit for a wireless charging capability.
5. Once the unibody is placed onto the station, the data from the RFID reader is finally post-processed using the primary microcontroller onboard to get the medical adherence data (including statistics, adherence score etc.).
6. All the necessary medical adherence data is then relayed onto the LED/LCD display. The data to be displayed on the display would be customizable and real-time.
7. For the backend server of Ocuelar to access, analyze and present the data, the primary microcontroller is equipped with a GSM shield which provides a 3G network service. This will allow all the necessary data to be accessed across multiple sites like the patient smartphone (for reminders), doctor’s clinic, insurance company platforms etc.
More information

Employees

Harsh Raj Chauhan
Admin
Harsh Raj Chauhan Engineer A team spirited "hands-on" experienced mechanical engineer with a blend of technical acumen, leadership and project management.